Clinical Observation on Treating Carotid Atherosclerosis with Yishenhuoxuehuatan Capsule
Objective To observe the clinical effect of Yishenhuoxuehuatan Capsule in the treatment of carotid atherosclerosis. Method 162 cases of carotid atherosclerosis were randomly divided into two groups:control group and treatment group. In addition to routine therapy of the control group, the therapy group was given Yishenhuoxuehuatan Capsule. After 24 weeks, observed the adverse reactions and differences of carotid artery intima-media thickness(IMT), plaque area, high-sensitivity C-reactive protein(hc-CRP) and serum lipids, serum cholesterol(TC), triglyceride(TG), high density lipoprotein(HDL-C), low-density lipoprotein(LDL-C) in the two groups. Result After treatment, carotid IMT, plaque area, hs-CRP, TC, TG, LDL-C of the two groups were significant decreased, HDL-C increased. Carotid IMT, plaque area, hs-CRP, TC, LDL-C of the treatment group were significantly lower than the control group, and no adverse reaction was detected in the course of treatment. Conclusion Yishenhuoxuehuatan Capsule has a better therapeutic effect on carotid atherosclerosis with a fairly good safety.